Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

Clinical trial NCT04546581 · COMPLETED

Trial details

NCT number: NCT04546581
Sponsor: University of Minnesota
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID COVID-19 SARS-CoV-2 SARS (Severe Acute Respiratory Syndrome)

Start date: 2020-10-08
Primary completion: 2021-05-21
Enrollment: 593

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.